Literature DB >> 24925051

Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity.

Dao-Fu Dai1, Paul E Swanson1, Eric V Krieger2, Iris W Liou2, Robert L Carithers2, Matthew M Yeh3.   

Abstract

Chronic right heart failure predisposes to hepatic passive congestion and centrizonal necrosis that may lead to hepatic fibrosis (cardiac sclerosis). Although there have been several studies on the histologic features of congestive hepatopathy, there is no available grading system. In this study we developed a novel grading system for congestive hepatic fibrosis. Liver biopsies were examined in patients with chronic heart failure of various etiologies including congenital heart disease, idiopathic cardiomyopathy, ischemic heart disease, and valvular heart disease. The cases with available echocardiography and/or right heart catheterization were included. Cases with other types of underlying chronic liver diseases, alcoholic liver disease, significant steatosis (>20%), malignant neoplasm, and acute heart failure or shock were excluded. After exclusion, 42 cases were included in the study. We herein proposed a novel congestive hepatic fibrosis score and correlated it with the right heart structure and function obtained by echocardiography and/or right heart catheterization. Our results showed that congestive hepatic fibrosis score is well correlated with the right atrial pressure (P for trend <0.001). The presence of portal fibrosis (congestive hepatic fibrosis scores 2 and 3) is associated with significantly higher right atrial pressure than those with no fibrosis (P<0.001) or with centrizonal fibrosis only (P=0.02). Congestive hepatic fibrosis score is also significantly associated with increasing severity of right atrial dilatation (P=0.03) and right ventricular dilatation (P=0.02), indicators for chronic volume and/or pressure overload. Other histopathologic features include sinusoidal dilatation and centrizonal hepatocyte atrophy. In summary, although sinusoidal dilatation and centrizonal fibrosis are the hallmarks of hepatic passive congestion, the presence of portal fibrosis is suggestive of more advanced disease, as it correlates with more severe impairment of right heart function, regardless of the etiologies of right heart failure. Congestive hepatic fibrosis score is a useful indicator of clinical severity.

Entities:  

Mesh:

Year:  2014        PMID: 24925051     DOI: 10.1038/modpathol.2014.79

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

1.  Routine Surveillance Catheterization is Useful in Guiding Management of Stable Fontan Patients.

Authors:  Neil D Patel; Patrick M Sullivan; Arash Sabati; Allison Hill; Chelsea Maedler-Kron; Shengmei Zhou; Nick Shillingford; Roberta Williams; Cheryl Takao; Sarah Badran
Journal:  Pediatr Cardiol       Date:  2020-01-24       Impact factor: 1.655

Review 2.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 3.  Liver fibrosis quantification.

Authors:  Sudhakar K Venkatesh; Michael S Torbenson
Journal:  Abdom Radiol (NY)       Date:  2022-01-12

4.  The two congested failing giants: heart and liver.

Authors:  Piero Portincasa
Journal:  Intern Emerg Med       Date:  2019-05-11       Impact factor: 3.397

Review 5.  From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

Authors:  Anna Sessa; Manon Allaire; Pascal Lebray; Mourad Medmoun; Alberto Tiritilli; Pierre Iaria; Jean-François Cadranel
Journal:  JHEP Rep       Date:  2021-01-27

6.  Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.

Authors:  Yoshitaka Fujimoto; Takashi Urashima; Daisuke Shimura; Reiji Ito; Sadataka Kawachi; Ichige Kajimura; Toru Akaike; Yoichiro Kusakari; Masako Fujiwara; Kiyoshi Ogawa; Nobuhito Goda; Hiroyuki Ida; Susumu Minamisawa
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 7.  Histopathological evaluation of liver fibrosis and cirrhosis regression.

Authors:  Regina C Lo; Haeryoung Kim
Journal:  Clin Mol Hepatol       Date:  2017-12-20

8.  Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Authors:  Marius M Hoeper; Raymond L Benza; Paul Corris; Marc de Perrot; Elie Fadel; Anne M Keogh; Christian Kühn; Laurent Savale; Walter Klepetko
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

9.  Histology and Glutamine Synthetase Immunoreactivity in Liver Biopsies From Patients With Congestive Heart Failure.

Authors:  Bela Horvath; Lei Zhu; Daniela Allende; Hao Xie; John Guirguis; Michael Cruise; Deepa T Patil; Robert O'Shea; John Rivas; Reyna Yordanka; Nan Lan; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2017-06-30

10.  Brain death organ donor supported by a left ventricular assist device showing unexpected congestive liver fibrosis: A case report.

Authors:  Hideya Kamei; Masahiko Komagome; Nobuhiko Kurata; Satoshi Ogiso; Yasuharu Onishi; Takanobu Hara; Mitsuhisa Takatsuki; Susumu Eguchi; Yasuhiro Ogura
Journal:  Int J Surg Case Rep       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.